Statements (35)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:ATCCode |
N07XX07
|
| gptkbp:brand |
gptkb:Ampyra
gptkb:Fampyra Fampridine |
| gptkbp:CASNumber |
504-24-5
|
| gptkbp:category |
gptkb:pyridines
amines potassium channel blockers |
| gptkbp:chemicalFormula |
C5H6N2
|
| https://www.w3.org/2000/01/rdf-schema#label |
4-aminopyridine
|
| gptkbp:IUPACName |
pyridin-4-amine
|
| gptkbp:KEGGID |
D02916
|
| gptkbp:legalStatus |
prescription only (varies by country)
|
| gptkbp:mechanismOfAction |
potassium channel blocker
|
| gptkbp:meltingPoint |
158–160 °C
|
| gptkbp:MeSH_ID |
D000465
|
| gptkbp:molecularWeight |
94.11 g/mol
|
| gptkbp:PubChem_CID |
135
CHEMBL1090 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
dizziness seizures insomnia |
| gptkbp:solubility |
soluble
|
| gptkbp:synonym |
gptkb:fampridine
4-AP |
| gptkbp:UNII |
R7T0EZ6389
|
| gptkbp:uses |
treatment of multiple sclerosis
research tool in neurophysiology |
| gptkbp:bfsParent |
gptkb:potassium_channels
gptkb:voltage-gated_potassium_channel gptkb:fampridine |
| gptkbp:bfsLayer |
7
|